Alexis’s research on predicting the impact of gene variants with eVIP2 was accepted by STAR Protocols. eVIP2 should be much easier to run for everyone. Great job Alexis!
UPDATE, SEP 7, 2022: The protocol is now available: https://doi.org/10.1016/j.xpro.2022.101651